News

Company   ImmuPharma PLC
TIDM         IMM
Headline     Directors' Dealings
Released    16:17 23-Jul-2009
Number     2020W16

FOR IMMEDIATE RELEASE

London, 23 July2009

Directors' Dealings Institutions increase stake

ImmuPharma PLC ('ImmuPharma' or the 'Company') (LSE:IMM) announces that a number of existing and new blue-chip institutional investors have purchased shares from Richard Warr and the Trusts of Richard Warr and Dimitri Dimitriou, who are two of ImmuPharma's founders and Directors. A total of 12.5 million ordinary shares (16.1% of the issued share capital) of 10 pence each in the Company, were placed by Noble & Company Limited at a price of 86 pence per share to institutional investors on 23 July 2009. Panmure Gordon is the NOMAD and Corporate Broker to the Company.

Following the disposal, the current holdings directly or through Trust are:

                                     Ordinary               Ordinary         Percentage
                                      Shares                 Shares             of shares
                                        Sold                   Retained            in issue

Richard Warr (1)             6,250,000             3,528,968            4.6%
Dimitri Dimitriou (2)        6,250,000              3,528,969           4.6%
Dr Zimmer & Family                    0            23,056,602           29.8%

(1) Ordinary shares of £0.10 held by Louvre Trustees Limited where the Warr family has a beneficial interest and shares held directly by Richard Warr.
(2) Ordinary shares of £0.10 held by Louvre Trustees Limited where the Dimitriou family has a beneficial interest.

Richard Warr, ImmuPharma's Chairman said: "We are delighted with the support received from our existing investors and the demand from new investors including M&G Investments. The allocation of these shares further increases ImmuPharma's free float with the aim of improving overall liquidity."

For further information please contact:

ImmuPharma PLC +44 20 7152 4080

Dimitri Dimitriou, Chief Executive Officer
Richard Warr, Chairman

Panmure Gordon & Co +44 151 243 0963

Andrew Burnett / Rakesh Sharma

Noble & Company Limited +44 20 7763 2335

John Millar

Buchanan Communications +44 20 7466 5000

Lisa Baderoon
Rebecca Skye Dietrich


Home About ImmuPharma Lead compounds Discovery pipeline Management team News For Investors Contact us	News Company ImmuPharma PLC TIDM IMM Headline Directors' Dealings Released 16:17 23-Jul-2009 Number 2020W16 FOR IMMEDIATE RELEASE London, 23 July2009 Directors' Dealings Institutions increase stake ImmuPharma PLC ('ImmuPharma' or the 'Company') (LSE:IMM) announces that a number of existing and new blue-chip institutional investors have purchased shares from Richard Warr and the Trusts of Richard Warr and Dimitri Dimitriou, who are two of ImmuPharma's founders and Directors. A total of 12.5 million ordinary shares (16.1% of the issued share capital) of 10 pence each in the Company, were placed by Noble & Company Limited at a price of 86 pence per share to institutional investors on 23 July 2009. Panmure Gordon is the NOMAD and Corporate Broker to the Company. Following the disposal, the current holdings directly or through Trust are: Ordinary Ordinary Percentage Shares Shares of shares Sold Retained in issue Richard Warr (1) 6,250,000 3,528,968 4.6% Dimitri Dimitriou (2) 6,250,000 3,528,969 4.6% Dr Zimmer & Family 0 23,056,602 29.8% (1) Ordinary shares of £0.10 held by Louvre Trustees Limited where the Warr family has a beneficial interest and shares held directly by Richard Warr. (2) Ordinary shares of £0.10 held by Louvre Trustees Limited where the Dimitriou family has a beneficial interest. Richard Warr, ImmuPharma's Chairman said: "We are delighted with the support received from our existing investors and the demand from new investors including M&G Investments. The allocation of these shares further increases ImmuPharma's free float with the aim of improving overall liquidity." For further information please contact: ImmuPharma PLC +44 20 7152 4080 Dimitri Dimitriou, Chief Executive Officer Richard Warr, Chairman Panmure Gordon & Co +44 151 243 0963 Andrew Burnett / Rakesh Sharma Noble & Company Limited +44 20 7763 2335 John Millar Buchanan Communications +44 20 7466 5000 Lisa Baderoon Rebecca Skye Dietrich ©2009 London Stock Exchange plc. All rights reserved